Research needs continue to evolve, creating demand for rising-interest biomarkers that may not yet be incorporated into standard assay portfolios. On-demand assays broaden access to emerging biomarkers, including protein forms and variants. This initial offering is particularly relevant to neurology research, with future expansion expected across oncology, inflammation and immunology, and cardiovascular, kidney, and metabolic (CKM) research.

On-demand assays
7
available





